- Home
- ZNTL vs BRAG Comparison
ZNTL vs BRAG Comparison
Compare ZNTL & BRAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- BRAG
- Stock Information
- Founded
- ZNTL 2014
- BRAG 2018
- Country
- ZNTL United States
- BRAG Canada
- Employees
- ZNTL N/A
- BRAG N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- BRAG Office Equipment/Supplies/Services
- Sector
- ZNTL Health Care
- BRAG Technology
- Exchange
- ZNTL Nasdaq
- BRAG Nasdaq
- Market Cap
- ZNTL 137.9M
- BRAG 117.8M
- IPO Year
- ZNTL 2020
- BRAG N/A
- Fundamental
- Price
- ZNTL $1.39
- BRAG $4.20
- Analyst Decision
- ZNTL Buy
- BRAG Strong Buy
- Analyst Count
- ZNTL 8
- BRAG 4
- Target Price
- ZNTL $8.53
- BRAG $7.50
- AVG Volume (30 Days)
- ZNTL 844.8K
- BRAG 39.0K
- Earning Date
- ZNTL 03-26-2025
- BRAG 03-20-2025
- Dividend Yield
- ZNTL N/A
- BRAG N/A
- EPS Growth
- ZNTL N/A
- BRAG N/A
- EPS
- ZNTL N/A
- BRAG N/A
- Revenue
- ZNTL $67,425,000.00
- BRAG $105,602,029.00
- Revenue This Year
- ZNTL N/A
- BRAG $16.92
- Revenue Next Year
- ZNTL N/A
- BRAG $9.87
- P/E Ratio
- ZNTL N/A
- BRAG N/A
- Revenue Growth
- ZNTL N/A
- BRAG 9.07
- 52 Week Low
- ZNTL $1.36
- BRAG $2.86
- 52 Week High
- ZNTL $16.21
- BRAG $7.00
- Technical
- Relative Strength Index (RSI)
- ZNTL 30.80
- BRAG 42.49
- Support Level
- ZNTL $1.78
- BRAG $4.05
- Resistance Level
- ZNTL $2.02
- BRAG $4.58
- Average True Range (ATR)
- ZNTL 0.15
- BRAG 0.20
- MACD
- ZNTL -0.02
- BRAG 0.00
- Stochastic Oscillator
- ZNTL 4.57
- BRAG 28.06
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as an Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.
About BRAG Bragg Gaming Group Inc.
Bragg Gaming Group Inc is predominantly a B2B online gaming technology platform and casino content aggregator. The Company's proprietary studios offer high-performing, data-driven casino gaming titles from in-house brands Wild Streak, Spin, Atomic Slot Lab, Indigo Magic and Oryx Gaming. It offers a full range of games including slot games, table games, card games, video bingo, scratch card games, virtual sports, and live dealer games which are featured on the company's PAM platform and also available for use on other gaming platforms offered by third parties. Geographically, the company generates a majority of its revenue from the Netherlands and the rest from Curacao, Malta, United States, Croatia, and other regions.